O	O	O	0	6	Second	Second	B-NP	JJ	O	2	NMOD	O
O	O	O	7	16	messenger	messenger	I-NP	NN	O	5	NMOD	O
O	O	O	17	19	up	up	B-ADVP	RB	O	5	NMOD	O
O	O	O	19	20	-	-	B-NP	HYPH	O	3	AMOD	O
O	O	O	20	30	regulation	regulation	I-NP	NN	O	11	SUB	O
O	O	O	31	33	of	of	B-PP	IN	O	5	NMOD	O
T9	B-Entity	B-Entity	34	42	androgen	androgen	B-NP	NN	B-DNA	10	NMOD	B-DNA
T9	I-Entity	I-Entity	43	51	receptor	receptor	I-NP	NN	I-DNA	10	NMOD	I-DNA
T9	I-Entity	I-Entity	52	56	gene	gene	I-NP	NN	I-DNA	10	NMOD	I-DNA
O	O	O	57	70	transcription	transcription	I-NP	NN	O	6	PMOD	O
O	O	O	71	73	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	74	80	absent	absent	B-ADJP	JJ	O	11	PRD	O
O	O	O	81	83	in	in	B-PP	IN	O	12	AMOD	O
O	O	O	84	92	androgen	androgen	B-NP	NN	B-cell_line	20	NMOD	B-cell_line
O	O	O	93	104	insensitive	insensitive	I-NP	JJ	I-cell_line	20	NMOD	I-cell_line
O	O	O	105	110	human	human	I-NP	JJ	I-cell_line	20	NMOD	I-cell_line
O	O	O	111	120	prostatic	prostatic	I-NP	JJ	I-cell_line	20	NMOD	I-cell_line
O	O	O	121	130	carcinoma	carcinoma	I-NP	NN	I-cell_line	20	NMOD	I-cell_line
O	O	O	131	135	cell	cell	I-NP	NN	I-cell_line	20	NMOD	I-cell_line
O	O	O	136	141	lines	line	I-NP	NNS	I-cell_line	13	PMOD	I-cell_line
O	O	O	141	142	,	,	O	,	O	27	P	O
O	O	O	143	145	PC	PC	B-NP	NN	B-cell_line	27	NMOD	B-cell_line
O	O	O	145	146	-	-	B-NP	HYPH	I-cell_line	27	P	I-cell_line
O	O	O	146	147	3	3	I-NP	CD	I-cell_line	27	NMOD	I-cell_line
O	O	O	148	151	and	and	I-NP	CC	O	27	NMOD	O
O	O	O	152	154	DU	DU	I-NP	NN	B-cell_line	27	NMOD	B-cell_line
O	O	O	154	155	-	-	B-NP	SYM	I-cell_line	28	NMOD	I-cell_line
O	O	O	155	158	145	145	B-NP	CD	I-cell_line	20	NMOD	I-cell_line
O	O	O	158	159	.	.	O	.	O	11	P	O

O	O	O	161	162	A	A	B-NP	DT	O	3	NMOD	O
O	O	O	163	174	theoretical	theoretical	I-NP	JJ	O	3	NMOD	O
O	O	O	175	182	pathway	pathway	I-NP	NN	O	15	SUB	O
O	O	O	183	185	of	of	B-PP	IN	O	3	NMOD	O
O	O	O	186	201	transcriptional	transcriptional	B-NP	JJ	O	6	NMOD	O
O	O	O	202	212	regulation	regulation	I-NP	NN	O	4	PMOD	O
O	O	O	213	215	of	of	B-PP	IN	O	6	NMOD	O
O	O	O	216	219	the	the	B-NP	DT	O	14	NMOD	O
T1	B-Protein	B-Protein	220	228	androgen	androgen	I-NP	NN	B-DNA	14	NMOD	B-DNA
T1	I-Protein	I-Protein	229	237	receptor	receptor	I-NP	NN	I-DNA	14	NMOD	I-DNA
O	O	O	238	239	(	(	O	(	I-DNA	14	NMOD	I-DNA
T2	B-Protein	B-Protein	239	241	AR	AR	B-NP	NN	I-DNA	14	NMOD	I-DNA
O	O	O	241	242	)	)	O	)	I-DNA	14	NMOD	I-DNA
O	O	O	243	247	gene	gene	B-NP	NN	I-DNA	7	PMOD	I-DNA
O	O	O	248	250	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	251	254	via	via	B-PP	IN	O	15	PRD	O
O	O	O	255	256	a	a	B-NP	DT	O	20	NMOD	O
T10	B-Entity	B-Entity	257	261	cAMP	cAMP	I-NP	NN	B-DNA	20	NMOD	B-DNA
T10	I-Entity	I-Entity	262	270	response	response	I-NP	NN	I-DNA	20	NMOD	I-DNA
T10	I-Entity	I-Entity	271	278	element	element	I-NP	NN	I-DNA	16	PMOD	I-DNA
O	O	O	279	280	(	(	O	(	O	23	DEP	O
T11	B-Entity	B-Entity	280	283	CRE	CRE	B-NP	NN	B-DNA	23	DEP	B-DNA
O	O	O	283	284	)	)	O	)	O	20	NMOD	O
O	O	O	285	292	present	present	B-ADJP	JJ	O	20	NMOD	O
O	O	O	293	295	in	in	B-PP	IN	O	24	AMOD	O
O	O	O	296	299	its	its	B-NP	PRP$	O	28	NMOD	O
T12	B-Entity	B-Entity	300	308	promoter	promoter	I-NP	NN	B-DNA	28	NMOD	B-DNA
T12	I-Entity	I-Entity	309	315	region	region	I-NP	NN	I-DNA	25	PMOD	I-DNA
O	O	O	316	317	(	(	O	(	O	35	DEP	O
O	O	O	317	318	-	-	B-NP	SYM	B-DNA	34	NMOD	B-DNA
O	O	O	318	321	508	508	B-NP	CD	I-DNA	34	NMOD	I-DNA
O	O	O	322	324	to	to	B-PP	TO	I-DNA	34	NMOD	I-DNA
O	O	O	325	326	-	-	B-NP	SYM	I-DNA	34	P	I-DNA
O	O	O	326	329	501	501	I-NP	CD	I-DNA	35	DEP	I-DNA
O	O	O	329	330	)	)	O	)	O	28	NMOD	O
O	O	O	330	331	.	.	O	.	O	15	P	O

O	O	O	332	337	After	After	B-PP	IN	O	15	VMOD	O
O	O	O	338	340	20	20	B-NP	CD	O	3	NMOD	O
O	O	O	341	342	h	h	I-NP	NN	O	1	PMOD	O
O	O	O	343	345	of	of	B-PP	IN	O	3	NMOD	O
O	O	O	346	357	stimulation	stimulation	B-NP	NN	O	4	PMOD	O
O	O	O	358	362	with	with	B-PP	IN	O	5	NMOD	O
T13	B-Entity	B-Entity	363	364	8	8	B-NP	CD	O	14	NMOD	O
T13	I-Entity	I-Entity	364	365	-	-	O	HYPH	O	14	NMOD	O
T13	I-Entity	I-Entity	365	370	bromo	bromo	O	AFX	B-cell_type	14	NMOD	B-cell_type
T13	I-Entity	I-Entity	370	371	-	-	O	HYPH	O	14	NMOD	O
T13	I-Entity	I-Entity	371	375	cAMP	cAMP	B-NP	NN	O	14	NMOD	O
O	O	O	375	376	,	,	O	,	O	14	P	O
T3	B-Protein	B-Protein	377	379	AR	AR	B-NP	NN	B-RNA	14	NMOD	B-RNA
O	O	O	380	384	mRNA	mRNA	I-NP	NN	I-RNA	6	PMOD	I-RNA
O	O	O	385	388	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	389	400	upregulated	upregulate	I-VP	VBN	O	15	VC	O
O	O	O	401	403	in	in	B-PP	IN	O	16	VMOD	O
O	O	O	404	409	LNCaP	LNCaP	B-NP	NN	B-cell_line	17	PMOD	B-cell_line
O	O	O	410	413	but	but	B-PP	CC	O	17	PMOD	O
O	O	O	414	417	not	not	B-PP	RB	O	21	PMOD	O
O	O	O	418	420	in	in	I-PP	IN	O	17	PMOD	O
O	O	O	421	427	either	either	O	CC	O	31	NMOD	O
O	O	O	428	430	PC	PC	B-NP	NN	B-protein	24	NMOD	B-protein
O	O	O	430	431	-	-	B-NP	HYPH	I-protein	31	NMOD	I-protein
O	O	O	431	432	3	3	I-NP	CD	I-protein	24	NMOD	I-protein
O	O	O	433	435	or	or	I-NP	CC	O	31	NMOD	O
O	O	O	436	438	DU	DU	I-NP	NN	B-cell_line	31	NMOD	B-cell_line
O	O	O	438	439	-	-	O	HYPH	I-cell_line	31	NMOD	I-cell_line
O	O	O	439	442	145	145	B-NP	CD	I-cell_line	31	NMOD	I-cell_line
O	O	O	443	447	cell	cell	I-NP	NN	I-cell_line	31	NMOD	I-cell_line
O	O	O	448	453	lines	line	I-NP	NNS	I-cell_line	21	PMOD	I-cell_line
O	O	O	453	454	.	.	O	.	O	15	P	O

O	O	O	455	457	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	458	462	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	463	475	demonstrated	demonstrate	I-VP	VBN	O	2	VC	O
O	O	O	476	480	that	that	B-SBAR	IN	O	22	DEP	O
O	O	O	481	484	the	the	B-NP	DT	O	6	NMOD	O
O	O	O	485	490	level	level	I-NP	NN	O	14	SUB	O
O	O	O	491	493	of	of	B-PP	IN	O	6	NMOD	O
T4	B-Protein	B-Protein	494	497	CRE	CRE	B-NP	NN	B-protein	10	NMOD	B-protein
T4	I-Protein	I-Protein	498	505	binding	binding	I-NP	NN	I-protein	10	NMOD	I-protein
T4	I-Protein	I-Protein	506	513	protein	protein	I-NP	NN	I-protein	7	PMOD	I-protein
O	O	O	514	515	(	(	O	(	O	13	DEP	O
T5	B-Protein	B-Protein	515	519	CREB	CREB	B-NP	NN	B-protein	13	DEP	B-protein
O	O	O	519	520	)	)	O	)	O	10	NMOD	O
O	O	O	521	524	was	be	B-VP	VBD	O	4	SBAR	O
O	O	O	525	528	the	the	B-NP	DT	O	16	NMOD	O
O	O	O	529	533	same	same	I-NP	JJ	O	14	PRD	O
O	O	O	534	536	in	in	B-PP	IN	O	14	VMOD	O
O	O	O	537	540	all	all	B-NP	DT	O	20	NMOD	O
O	O	O	541	545	cell	cell	I-NP	NN	B-cell_line	20	NMOD	B-cell_line
O	O	O	546	551	lines	line	I-NP	NNS	I-cell_line	17	PMOD	I-cell_line
O	O	O	552	555	and	and	O	CC	O	22	DEP	O
O	O	O	556	560	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	561	564	the	the	B-NP	DT	O	28	NMOD	O
O	O	O	565	573	putative	putative	I-NP	JJ	O	28	NMOD	O
T6	B-Protein	B-Protein	574	576	AR	AR	I-NP	NN	B-protein	28	NMOD	B-protein
T14	B-Entity	B-Entity	576	577	-	-	B-NP	HYPH	O	28	P	O
T14	I-Entity	I-Entity	577	580	CRE	CRE	I-NP	NN	B-protein	28	NMOD	B-protein
O	O	O	581	586	forms	form	I-NP	NNS	I-protein	22	SBAR	I-protein
O	O	O	587	595	specific	specific	B-NP	JJ	O	31	AMOD	O
O	O	O	596	599	and	and	I-NP	CC	O	31	AMOD	O
O	O	O	600	610	compatible	compatible	I-NP	JJ	O	33	NMOD	O
O	O	O	611	618	protein	protein	I-NP	NN	O	33	NMOD	O
O	O	O	619	631	interactions	interaction	I-NP	NNS	O	28	OBJ	O
O	O	O	632	636	with	with	B-PP	IN	O	33	NMOD	O
T7	B-Protein	B-Protein	637	641	CREB	CREB	B-NP	NN	B-protein	34	PMOD	B-protein
O	O	O	641	642	.	.	O	.	O	2	P	O

O	O	O	643	646	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	647	654	ability	ability	I-NP	NN	O	13	SUB	O
O	O	O	655	657	to	to	B-VP	TO	O	4	VMOD	O
O	O	O	658	666	regulate	regulate	I-VP	VB	O	2	NMOD	O
T8	B-Protein	B-Protein	667	669	AR	AR	B-NP	NN	B-DNA	6	NMOD	B-DNA
O	O	O	670	674	gene	gene	I-NP	NN	I-DNA	7	NMOD	I-DNA
O	O	O	675	688	transcription	transcription	I-NP	NN	O	4	OBJ	O
O	O	O	689	692	via	via	B-PP	IN	O	4	VMOD	O
O	O	O	693	696	the	the	B-NP	DT	O	12	NMOD	O
O	O	O	697	703	second	second	I-NP	JJ	O	12	NMOD	O
O	O	O	704	713	messenger	messenger	I-NP	NN	O	12	NMOD	O
O	O	O	714	721	pathway	pathway	I-NP	NN	O	8	PMOD	O
O	O	O	722	724	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	725	729	lost	lose	I-VP	VBN	O	13	VC	O
O	O	O	730	732	in	in	B-PP	IN	O	14	VMOD	O
O	O	O	733	736	the	the	B-NP	DT	O	25	NMOD	O
O	O	O	737	739	PC	PC	I-NP	NN	B-cell_line	25	NMOD	B-cell_line
O	O	O	739	740	-	-	B-NP	HYPH	I-cell_line	25	NMOD	I-cell_line
O	O	O	740	741	3	3	I-NP	CD	I-cell_line	25	NMOD	I-cell_line
O	O	O	742	745	and	and	I-NP	CC	I-cell_line	25	NMOD	I-cell_line
O	O	O	746	748	DU	DU	I-NP	NN	I-cell_line	25	NMOD	I-cell_line
O	O	O	748	749	-	-	O	HYPH	I-cell_line	25	NMOD	I-cell_line
O	O	O	749	752	145	145	B-NP	CD	I-cell_line	25	NMOD	I-cell_line
O	O	O	753	757	cell	cell	I-NP	NN	I-cell_line	25	NMOD	I-cell_line
O	O	O	758	763	lines	line	I-NP	NNS	I-cell_line	15	PMOD	I-cell_line
O	O	O	763	764	.	.	O	.	O	13	P	O

O	O	O	765	769	This	This	B-NP	DT	O	2	SUB	O
O	O	O	770	773	may	may	B-VP	MD	O	0	ROOT	O
O	O	O	774	776	be	be	I-VP	VB	O	2	VC	O
O	O	O	777	779	an	an	B-NP	DT	O	7	NMOD	O
O	O	O	780	789	important	important	I-NP	JJ	O	6	AMOD	O
O	O	O	790	797	primary	primary	I-NP	JJ	O	7	NMOD	O
O	O	O	798	807	mechanism	mechanism	I-NP	NN	O	3	PRD	O
O	O	O	808	810	of	of	B-PP	IN	O	7	NMOD	O
O	O	O	811	819	androgen	androgen	B-NP	NN	O	10	NMOD	O
O	O	O	820	833	insensitivity	insensitivity	I-NP	NN	O	8	PMOD	O
O	O	O	834	836	in	in	B-PP	IN	O	7	NMOD	O
O	O	O	837	845	prostate	prostate	B-NP	NN	O	13	NMOD	O
O	O	O	846	852	cancer	cancer	I-NP	NN	O	11	PMOD	O
O	O	O	852	853	.	.	O	.	O	2	P	O
